F-18-fluorodeoxyglucose positron emission tomography for visualization of lipodystrophy in HIV-infected patients

AIDS. 2004 Dec 3;18(18):2430-2.

Authors

Chantal P Bleeker-Rovers¹, André J van der Ven, Bert Zomer, Lioe-Fee de Geus-Oei, Paul Smits, Frans H M Corstens, Peter P Koopmans, Wim J G Oyen

Affiliation

¹ Department of Internal Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.

PMID: 15622321

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Antiretroviral Therapy, Highly Active / adverse effects*
Blood Glucose / metabolism*
Fluorodeoxyglucose F18* / pharmacokinetics
HIV Infections / drug therapy*
HIV-Associated Lipodystrophy Syndrome / diagnostic imaging*
HIV-Associated Lipodystrophy Syndrome / metabolism
Humans
Male
Middle Aged
Positron-Emission Tomography / methods
Prospective Studies
Radiopharmaceuticals* / pharmacokinetics

Substances

Blood Glucose
Radiopharmaceuticals
Fluorodeoxyglucose F18